Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD80 (clone AB0Z0Z7J). We employs the HBV (pUC-GFP-AR-XbaI) vector components and the SynExpress system of the miRNA Knock-in/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CD80
Clone
AB0Z0Z7J
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
pUC
Effector Gene
AR
Insertion Sites
XbaI
Gene Modification
Knock-in
Modification Domain
miRNA
Carrier Type
HBV
Transformation Accuracy
0.99
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.